QHSLab (QHSLab) ROCE % : 0.00% (As of Mar. 2024)

View and export this data going back to 1990. Start your Free Trial

What is QHSLab ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. QHSLab's annualized ROCE % for the quarter that ended in Mar. 2024 was 0.00%.

QHSLab ROCE % Historical Data

The historical data trend for QHSLab's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QHSLab ROCE % Chart

QHSLab Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-672.73

-74.01

-71.13

QHSLab Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															-344.48	-	-	-	-

QHSLab ROCE % Calculation

QHSLab's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-0.238	/	( ( (1.957 - 1.707)	+	(1.681 - 2.057) )	/ 2 )
	=	-0.238	/	( (0.25	+	-0.376)	/ 2 )
	=	-0.238	/	-0.063
	=	377.78 %

QHSLab's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	0.056	/	( ( (1.681 - 2.057)	+	(1.731 - 2.113) )	/ 2 )
	=	0.056	/	( ( -0.376	+	-0.382 )	/ 2 )
	=	0.056	/	-0.379
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

QHSLab (OTCPK:USAQ) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

QHSLab ROCE % Related Terms

Thank you for viewing the detailed overview of QHSLab's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

QHSLab (QHSLab) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QHSLab Inc (OTCPK:USAQ) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

901 Northpoint Parkway, Suite 302, West Palm Beach, FL, USA, 33407

Website

https://www.qhslab.com

QHSLab Inc is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. It is a medical device technology and software as a service (SaaS) company focused on enabling primary care physicians (PCPs) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.

Executives

Troy James Grogan	director, 10 percent owner, officer: CEO/Director	5480 N OCEAN DR B1D, SINGER ISLAND FL 33404
Richard J Rubin	director, 10 percent owner, officer: CEO & Chairman	90 JOHN STREET, SUITE 626, NEW YORK NY 10038